U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C12H14NO3.Cl
Molecular Weight 255.697
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of COTARNINE CHLORIDE

SMILES

[Cl-].COC1=C2OCOC2=CC3=C1C=[N+](C)CC3

InChI

InChIKey=BWQAGVANIBSWBW-UHFFFAOYSA-M
InChI=1S/C12H14NO3.ClH/c1-13-4-3-8-5-10-12(16-7-15-10)11(14-2)9(8)6-13;/h5-6H,3-4,7H2,1-2H3;1H/q+1;/p-1

HIDE SMILES / InChI
Cotarninium is a uterotonic agent. It increases the tone of smooth muscles of internal organs, particularly the uterus. Indicated for the treatment of uterus subinvolution (after childbirth and abortion), dysfunctional uterine bleeding and bleeding due to fibroids and inflammatory processes. Side effects are nausea, allergic reactions. Contraindications are pregnancy and hypersensitivity to the agent.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
STYPTICIN

Approved Use

Indicated for the treatment of delayed uterine involution, uterine bleeding after childbirth, abortion and others.

Launch Date

1964
Primary
STYPTICIN

Approved Use

Indicated for the treatment of delayed uterine involution, uterine bleeding after childbirth, abortion and others.

Launch Date

1964
PubMed

PubMed

TitleDatePubMed
[The detection of abortion agents in biological material].
1992 Jan-Mar
Noscapine inhibits tumor growth with little toxicity to normal tissues or inhibition of immune responses.
2000 Jul
Validated stability-indicating TLC method for the determination of noscapine.
2009 Jul
Metabolic pathway profiling of the derivative of important herbal component noscapine.
2016 Feb
Metal-Free Activation of a C(sp)-H Bond of Aryl Acetylenes.
2016 Oct 10
A new approach to alkaloid-like systems: synthesis and crystal structure of 1-(2-acetyl-11-meth-oxy-5,6-di-hydro-[1,3]dioxolo[4,5-g]pyrrolo-[2,1-a]isoquinolin-1-yl)propan-2-one.
2017 Nov 1
Patents

Patents

Sample Use Guides

Subcutaneous: 1 ml of 2-5% solution Topical: Locally 1-2% solution Oral: 50-100 mg 3 times a day
Route of Administration: Other
In Vitro Use Guide
Unknown
Name Type Language
COTARNINE CHLORIDE
MART.   MI  
Common Name English
COTARNIN CHLORIDE
WHO-DD  
Common Name English
NSC-24824
Code English
COTARNINIUM CHLORIDE
Common Name English
COTARNINE CHLORIDE [MART.]
Common Name English
1,3-DIOXOLO(4,5-G)ISOQUINOLINIUM, 7,8-DIHYDRO-4-METHOXY-6-METHYL-, CHLORIDE (1:1)
Systematic Name English
STYPTICIN
Brand Name English
Cotarnin chloride [WHO-DD]
Common Name English
COTARNINE CHLORIDE [MI]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C221
Created by admin on Fri Dec 15 17:13:42 GMT 2023 , Edited by admin on Fri Dec 15 17:13:42 GMT 2023
Code System Code Type Description
PUBCHEM
160908
Created by admin on Fri Dec 15 17:13:42 GMT 2023 , Edited by admin on Fri Dec 15 17:13:42 GMT 2023
PRIMARY
FDA UNII
03F6B8N3QN
Created by admin on Fri Dec 15 17:13:42 GMT 2023 , Edited by admin on Fri Dec 15 17:13:42 GMT 2023
PRIMARY
ChEMBL
CHEMBL1616073
Created by admin on Fri Dec 15 17:13:42 GMT 2023 , Edited by admin on Fri Dec 15 17:13:42 GMT 2023
PRIMARY
CAS
10018-19-6
Created by admin on Fri Dec 15 17:13:42 GMT 2023 , Edited by admin on Fri Dec 15 17:13:42 GMT 2023
PRIMARY
EPA CompTox
DTXSID80905241
Created by admin on Fri Dec 15 17:13:42 GMT 2023 , Edited by admin on Fri Dec 15 17:13:42 GMT 2023
PRIMARY
NSC
24824
Created by admin on Fri Dec 15 17:13:42 GMT 2023 , Edited by admin on Fri Dec 15 17:13:42 GMT 2023
PRIMARY
MERCK INDEX
m3810
Created by admin on Fri Dec 15 17:13:42 GMT 2023 , Edited by admin on Fri Dec 15 17:13:42 GMT 2023
PRIMARY Merck Index
NCI_THESAURUS
C79997
Created by admin on Fri Dec 15 17:13:42 GMT 2023 , Edited by admin on Fri Dec 15 17:13:42 GMT 2023
PRIMARY
ECHA (EC/EINECS)
233-012-1
Created by admin on Fri Dec 15 17:13:42 GMT 2023 , Edited by admin on Fri Dec 15 17:13:42 GMT 2023
PRIMARY